DDX39BP2

Across TCGA pan-cancer cohorts, DDX39BP2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated DDX39BP2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher DDX39BP2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DDX39BP2 expression acts as an unfavorable survival marker, although some lineages such as LGG and SKCM show a favorable association.

KIRC, KIRP, and ESCA are the cancer types where DDX39BP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.542	0.714	<.001	108	view →
KIRP	OS	Quartile	III,IV	0.220	0.727	<.001	50	view →
ESCA	OS	Tertile	IV	0.127	0.571	.003	36	view →
KICH	OS	Median	All	0.645	1.000	.001	32	view →
LIHC	OS	Tertile	All	0.659	0.832	<.001	29	view →
THCA	DFS	Median	III,IV	0.827	0.954	.002	27	view →
LGG	OS	Quartile	All	0.886	0.736	.001	23	view →
UCEC	DFS	Median	All	0.785	0.864	.011	12	view →
SKCM	OS	Quartile	III,IV	0.462	0.158	.014	8	view →
CESC	DFS	Median	II,III,IV	0.878	0.693	.008	8	view →
PCPG	DFS	Quartile	All	0.777	1.000	.002	8	view →
COAD	OS	Median	II,III,IV	0.779	0.894	.012	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

DDX39BP2–KIRC (DFS)

Open the KIRC breakdown →